13F filer · CIK 1032165
FRAZIER MANAGEMENT LLC
SEATTLE, WA · filing since Q4 2015 · last filing Nov 14, 2022
Reported value
$1.1B
+$256.8M vs prior
Positions
26
New / sold out
2 / 1
Added / reduced
4 / 3
Turnover
6.9%
buys $102.4M · sells $69.4M
Top-10 weight
86.4%
Biggest buys vs Q1 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | VAXCYTE INC | +2,309,554 | – | +$73.0M |
| New | IVERIC BIO INC | +2,364,500 | – | +$12.1M |
| Added | ROCKET PHARMACEUTICALS INC | +318,000 | +151.4% | +$6.7M |
| Added | SYNDAX PHARMACEUTICALS INC | +329,334 | +33.2% | +$4.9M |
| Added | ADVERUM BIOTECHNOLOGIES INC | +158,700 | +12.4% | +$3.3M |
| Added | TRILLIUM THERAPEUTICS INC | +311,191 | +12.7% | +$2.5M |
Biggest sells vs Q1 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | PHATHOM PHARMACEUTICALS INC | -1,456,854 | -20.0% | $-47.9M |
| Reduced | IOVANCE BIOTHERAPEUTICS INC | -437,666 | -25.0% | $-12.0M |
| Sold out | MILLENDO THERAPEUTICS INC | -1,396,615 | -100.0% | $-7.4M |
| Reduced | ENTASIS THERAPEUTICS HLDGS I | -700,000 | -66.7% | $-2.1M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2020
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ARCUTIS BIOTHERAPEUTICS INCCOM | 10,542,790 | $318.8M | 28.00% |
| 2 | PHATHOM PHARMACEUTICALS INCCOM | 5,827,415 | $191.8M | 16.84% |
| 3 | PASSAGE BIO INCCOM | 5,009,219 | $136.9M | 12.02% |
| 4 | VAXCYTE INCCOM | 2,309,554 | $73.0M | 6.41% |
| 5 | MIRUM PHARMACEUTICALS INCCOM | 3,566,912 | $69.4M | 6.10% |
| 6 | ANAPTYSBIO INCCOM | 2,316,447 | $51.7M | 4.54% |
| 7 | TRANSLATE BIO INCCOM | 2,182,789 | $39.1M | 3.43% |
| 8 | KRYSTAL BIOTECH INCCOM | 895,000 | $37.1M | 3.26% |
| 9 | IOVANCE BIOTHERAPEUTICS INCCOM | 1,312,999 | $36.0M | 3.16% |
| 10 | ADVERUM BIOTECHNOLOGIES INCCOM | 1,437,028 | $30.0M | 2.63% |
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.